We are currently developing a novel breast cancer tumorigenesis model that diverges from the currently-accepted model. Our goal is to identify new biomarkers that may be used to develop targeted therapies for breast cancer. Our unique approach to breast cancer research has the potential to pave the way for personalized therapies that can improve treatment outcomes for individuals diagnosed with breast cancer.